- Home
- MSGM vs APM Comparison
MSGM vs APM Comparison
Compare MSGM & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGM
- APM
- Stock Information
- Founded
- MSGM 2018
- APM 2010
- Country
- MSGM United States
- APM United Kingdom
- Employees
- MSGM N/A
- APM N/A
- Industry
- MSGM Computer Software: Prepackaged Software
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- MSGM Technology
- APM Health Care
- Exchange
- MSGM Nasdaq
- APM Nasdaq
- Market Cap
- MSGM 17.4M
- APM 18.9M
- IPO Year
- MSGM 2021
- APM 2018
- Fundamental
- Price
- MSGM $2.95
- APM $1.71
- Analyst Decision
- MSGM
- APM
- Analyst Count
- MSGM 0
- APM 0
- Target Price
- MSGM N/A
- APM N/A
- AVG Volume (30 Days)
- MSGM 28.0K
- APM 20.3M
- Earning Date
- MSGM 08-13-2025
- APM 04-30-2025
- Dividend Yield
- MSGM N/A
- APM N/A
- EPS Growth
- MSGM N/A
- APM N/A
- EPS
- MSGM 0.00
- APM N/A
- Revenue
- MSGM $8,127,065.00
- APM N/A
- Revenue This Year
- MSGM $69.07
- APM N/A
- Revenue Next Year
- MSGM $30.56
- APM N/A
- P/E Ratio
- MSGM $7.02
- APM N/A
- Revenue Growth
- MSGM N/A
- APM N/A
- 52 Week Low
- MSGM $0.73
- APM $0.46
- 52 Week High
- MSGM $3.92
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- MSGM 44.60
- APM 50.27
- Support Level
- MSGM $2.83
- APM $2.17
- Resistance Level
- MSGM $3.00
- APM $2.65
- Average True Range (ATR)
- MSGM 0.18
- APM 0.34
- MACD
- MSGM -0.01
- APM -0.01
- Stochastic Oscillator
- MSGM 18.09
- APM 18.69
About MSGM Motorsport Games Inc.
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.